| Financial Year |
March 31 2023 |
| Monetary Funds |
755,633,196.59 |
| Held-for-trading Financial Assets |
140,993,042.56 |
| Notes Receivable |
-- |
| Accounts Receivable |
22,865,563.56 |
| Advances to Suppliers |
162,896,199.14 |
| Other Receivables |
54,767,419.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
381,867,967.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
140,699,221.34 |
| Total Current Assets |
1,689,644,941.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
507,135,713.86 |
| Under-construction Projects |
752,690,474.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
214,664,988.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
15,137.78 |
| Deferred Income Tax Assets |
3,982,817.22 |
| Other Non-Current Assets |
112,757,137.65 |
| Sub-Total of Non-Current Assets |
1,591,246,269.42 |
| Total Assets |
3,280,891,210.86 |
| Short-Term Loans |
159,845,790.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
292,008,947.12 |
| Accounts Payable |
204,789,569.70 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,224,333.21 |
| Taxes Payable |
11,509,662.42 |
| Interest Payable |
1,405,958.83 |
| Dividend Payable |
-- |
| Other payables |
3,736,697.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
21,364,000.00 |
| Other Current Liabilities |
10,391,380.54 |
| Sub-Total of Current Liabilities |
801,581,854.62 |
| Long-term Loans |
198,875,720.75 |
| Bonds Payable |
488,334,975.93 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
577,083.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
732,154,285.89 |
| Total Liabilities |
1,533,736,140.51 |
| Paid-In Capital(Or Share Stock) |
124,800,873.00 |
| Capital Surplus |
823,672,196.55 |
| Surplus Reserve |
62,400,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
647,111,943.13 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,747,155,070.35 |
| Owner's Equity（Stockholder's Equity） |
1,747,155,070.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,280,891,210.86 |
